Title | Type | SJR | H index | Total Docs. (2009) | Total Docs. (3years) | Total Refs. (2009) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2009) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
191 | Advances in Gastrointestinal Cancers | journal | 0.100 Q4 | 1 | 5 | 96 | 66 | 1 | 48 | 0.02 | 13.20 | |
190 | Journal of Dalian Medical University | journal | 0.100 Q4 | 5 | 190 | 365 | 1993 | 1 | 365 | 0.00 | 10.49 | |
189 | Journal of Leukemia and Lymphoma | journal | 0.100 Q4 | 5 | 208 | 125 | 2833 | 1 | 125 | 0.01 | 13.62 | |
188 | Women's Oncology Review | journal | 0.101 | 4 | 0 | 36 | 0 | 0 | 34 | 0.00 | 0.00 | |
187 | Enhancer - Biotherapy of Cancer | journal | 0.102 Q4 | 0 | 0 | 15 | 0 | 0 | 11 | 0.00 | 0.00 | |
186 | Tumor Research | journal | 0.102 Q4 | 3 | 0 | 13 | 0 | 0 | 13 | 0.00 | 0.00 | |
185 | Chinese Journal of Clinical Oncology | journal | 0.103 Q4 | 11 | 237 | 1204 | 3087 | 32 | 1204 | 0.02 | 13.03 | |
184 | ecancermedicalscience | journal | 0.103 Q4 | 47 | 31 | 7 | 1018 | 0 | 7 | 0.00 | 32.84 | |
183 | Journal of Breast Cancer | journal | 0.103 Q4 | 48 | 53 | 35 | 1190 | 5 | 35 | 0.14 | 22.45 | |
182 | Turkish Journal of Cancer | journal | 0.104 Q4 | 10 | 23 | 84 | 480 | 10 | 84 | 0.11 | 20.87 | |
181 | Tumor | journal | 0.105 Q4 | 9 | 232 | 421 | 2870 | 21 | 416 | 0.05 | 12.37 | |
180 | Cancer cytopathology | journal | 0.108 Q4 | 68 | 56 | 9 | 1375 | 4 | 8 | 0.44 | 24.55 | |
179 | Voprosy Onkologii | journal | 0.108 Q4 | 13 | 147 | 377 | 2063 | 20 | 377 | 0.06 | 14.03 | |
178 | Chinese Journal of Cancer Biotherapy | journal | 0.109 Q4 | 5 | 131 | 129 | 2871 | 9 | 126 | 0.07 | 21.92 | |
177 | Biotherapy | journal | 0.110 Q4 | 8 | 58 | 187 | 976 | 15 | 187 | 0.12 | 16.83 | |
176 | Chinese Journal of Lung Cancer | journal | 0.111 Q4 | 21 | 263 | 379 | 5158 | 69 | 378 | 0.20 | 19.61 | |
175 | Annals of Cancer Research and Therapy | journal | 0.112 Q4 | 7 | 12 | 26 | 148 | 2 | 25 | 0.10 | 12.33 | |
174 | Chinese Journal of Cancer Research (discontinued) | journal | 0.116 Q4 | 41 | 50 | 174 | 1121 | 22 | 174 | 0.17 | 22.42 | |
173 | Nowotwory | journal | 0.116 Q4 | 11 | 69 | 200 | 1578 | 16 | 197 | 0.09 | 22.87 | |
172 | Reports of Practical Oncology and Radiotherapy | journal | 0.116 Q4 | 36 | 28 | 112 | 475 | 13 | 105 | 0.11 | 16.96 | |
171 | Onkologia Polska | journal | 0.117 Q4 | 7 | 25 | 104 | 518 | 9 | 104 | 0.12 | 20.72 | |
170 | Breast Cancer Online | journal | 0.120 Q4 | 3 | 10 | 58 | 271 | 7 | 58 | 0.04 | 27.10 | |
169 | Translational Oncogenomics | journal | 0.120 Q4 | 11 | 0 | 11 | 0 | 2 | 11 | 0.20 | 0.00 | |
168 | Oncology Reviews | journal | 0.121 Q4 | 31 | 30 | 60 | 1827 | 12 | 56 | 0.20 | 60.90 | |
167 | Journal of Cell and Molecular Biology | journal | 0.124 Q4 | 13 | 0 | 25 | 0 | 9 | 23 | 0.36 | 0.00 | |
166 | Japanese Journal of Cancer and Chemotherapy | journal | 0.126 Q4 | 25 | 653 | 1530 | 5695 | 195 | 1528 | 0.11 | 8.72 | |
165 | Cancer Forum | journal | 0.128 Q4 | 15 | 31 | 100 | 1076 | 10 | 97 | 0.05 | 34.71 | |
164 | Current Hematologic Malignancy Reports | journal | 0.130 Q4 | 44 | 33 | 97 | 1307 | 9 | 95 | 0.08 | 39.61 | |
163 | Molecular Medicine Reports | journal | 0.138 Q4 | 86 | 158 | 141 | 4463 | 32 | 141 | 0.23 | 28.25 | |
162 | Clinical and Experimental Medical Letters | journal | 0.141 Q4 | 6 | 41 | 86 | 785 | 8 | 86 | 0.09 | 19.15 | |
161 | International Journal of Cancer Research (discontinued) | journal | 0.145 Q4 | 18 | 17 | 85 | 663 | 33 | 85 | 0.39 | 39.00 | |
160 | Current Cancer Therapy Reviews | journal | 0.173 Q4 | 17 | 32 | 100 | 3033 | 29 | 96 | 0.22 | 94.78 | |
159 | Advances in Breast Cancer | journal | 0.189 Q4 | 4 | 26 | 112 | 416 | 5 | 43 | 0.03 | 16.00 | |
158 | National Toxicology Program technical report series | journal | 0.189 | 22 | 2 | 24 | 0 | 24 | 24 | 1.00 | 0.00 | |
157 | Journal of the Egyptian National Cancer Institute | journal | 0.199 Q4 | 28 | 13 | 88 | 0 | 56 | 88 | 0.05 | 0.00 | |
156 | Journal of B.U.ON. | journal | 0.211 Q4 | 37 | 151 | 299 | 4363 | 180 | 276 | 0.63 | 28.89 | |
155 | Update on Cancer Therapeutics | journal | 0.220 Q4 | 13 | 9 | 62 | 819 | 46 | 61 | 1.04 | 91.00 | |
154 | European Journal of Cancer, Supplement | journal | 0.225 Q4 | 29 | 5 | 203 | 96 | 142 | 192 | 0.48 | 19.20 | |
153 | Progress in Experimental Tumor Research | book series | 0.267 Q4 | 20 | 0 | 27 | 0 | 14 | 26 | 0.52 | 0.00 | |
152 | Bulletin du Cancer | journal | 0.287 Q4 | 44 | 200 | 593 | 5610 | 484 | 537 | 0.79 | 28.05 | |
151 | Supportive Cancer Therapy | journal | 0.314 Q4 | 15 | 0 | 66 | 0 | 69 | 55 | 1.32 | 0.00 | |
150 | Asian Pacific Journal of Cancer Prevention | journal | 0.335 Q4 | 91 | 242 | 434 | 6812 | 507 | 401 | 1.00 | 28.15 | |
149 | Tumori | journal | 0.345 Q4 | 59 | 143 | 483 | 3586 | 380 | 453 | 0.72 | 25.08 | |
148 | Targeted Oncology | journal | 0.347 Q4 | 59 | 31 | 96 | 2034 | 43 | 85 | 0.42 | 65.61 | |
147 | Cancer Microenvironment | journal | 0.357 Q4 | 51 | 12 | 15 | 618 | 22 | 15 | 1.47 | 51.50 | |
146 | Journal of Biological Regulators and Homeostatic Agents | journal | 0.372 Q3 | 56 | 39 | 62 | 1200 | 147 | 54 | 2.74 | 30.77 | |
145 | Clinical and Translational Oncology | journal | 0.387 Q3 | 61 | 155 | 471 | 4859 | 458 | 415 | 1.02 | 31.35 | |
144 | Oncology Research and Treatment | journal | 0.390 Q3 | 55 | 150 | 343 | 2957 | 371 | 271 | 1.06 | 19.71 | |
143 | In Vivo | journal | 0.392 | 72 | 154 | 452 | 4885 | 595 | 450 | 1.30 | 31.72 | |
142 | Brain Tumor Pathology | journal | 0.394 Q3 | 45 | 16 | 47 | 394 | 60 | 47 | 1.37 | 24.63 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®